Cargando…

Central obesity & dyslipidemia in HIV patients on antiretroviral therapy

Detalles Bibliográficos
Autores principales:	Kumar, Sanjay, Dhanwal, Dinesh Kumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362732/ https://www.ncbi.nlm.nih.gov/pubmed/30665998 http://dx.doi.org/10.4103/ijmr.IJMR_1190_18

Ejemplares similares

Hypothalamic pituitary dysfunction in acute nonmycobacterial infections of central nervous system
por: Dhanwal, Dinesh K., et al.
Publicado: (2011)

Thyroid disorders and bone mineral metabolism
por: Dhanwal, Dinesh Kumar
Publicado: (2011)

Oncogenic osteomalacia: A reversible metabolic bone disorder
por: Dhanwal, Dinesh Kumar
Publicado: (2010)

The Benefits of Early Antiretroviral Therapy for HIV Infection: How Early is Early Enough?
por: Lee, Sulggi A., et al.
Publicado: (2016)

Leptin dysfunction and the risk of dyslipidemia and metabolic syndrome in Romanian HIV-infected patients undergoing antiretroviral therapy
por: Tilişcan, Cătălin, et al.
Publicado: (2014)

Dyslipidemia among HIV-infected Patients with Tuberculosis Taking Once-daily Nonnucleoside Reverse-Transcriptase Inhibitor–Based Antiretroviral Therapy in India
por: Padmapriyadarsini, Chandrasekaran, et al.
Publicado: (2011)

Kelussia odoratissima Mozaffarian and dyslipidemia
por: Dehghan Shahreza, Fatemeh
Publicado: (2015)

Cardiovascular Disease and Antiretroviral Therapy
por: Jarwani, Bhavesh
Publicado: (2019)

Prevalence of Dyslipidemia Among Antiretroviral-Naive HIV-Infected Individuals in China
por: Shen, Yinzhong, et al.
Publicado: (2015)

Dietary management of dyslipidemia in HIV-infected young adults in antiretroviral treatment
por: Nițescu, Maria, et al.
Publicado: (2014)

Combination anti‐HIV antibodies to achieve antiretroviral therapy‐free virological suppression in infected individuals
por: Rai, M. Ali, et al.
Publicado: (2022)

Highly active antiretroviral treatment for the prevention of HIV transmission
por: Granich, Reuben, et al.
Publicado: (2010)

Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count
por: Bigna, Jean Joel R., et al.
Publicado: (2016)

Identification of Immune Activation Profiles That May Predict Morbidity During Antiretroviral Therapy Treated HIV Infection
por: Funderburg, Nicholas T.
Publicado: (2016)

The first decade of antiretroviral therapy in Africa
por: Ford, Nathan, et al.
Publicado: (2011)

Risk factors and longitudinal changes of dyslipidemia among Chinese people living with HIV receiving antiretroviral therapy
por: Li, Xiuxia, et al.
Publicado: (2023)

Erectile Dysfunction Among HIV Patients Undergoing Highly Active Antiretroviral Therapy: Dyslipidemia as a Main Risk Factor
por: Romero-Velez, Gustavo, et al.
Publicado: (2014)

A New Treatment Strategy for Diabetic Dyslipidemia?
por: Kothari, Vishal, et al.
Publicado: (2020)

Dyslipidemias and Elevated Cardiovascular Risk on Lopinavir-Based Antiretroviral Therapy in Cambodia
por: Limsreng, Setha, et al.
Publicado: (2016)

Hypopituitarism in the tropics
por: Kalra, Sanjay, et al.
Publicado: (2011)

First-line antiretroviral therapy and dyslipidemia in people living with HIV-1 in Cameroon: a cross-sectional study
por: Pefura Yone, Eric Walter, et al.
Publicado: (2011)

Sustaining the community dispensation strategy of HIV antiretroviral through community participation
por: Kameni, Bibiane Siaheu, et al.
Publicado: (2019)

Vanishing large ovarian cyst with thyroxine therapy
por: Dharmshaktu, Pramila, et al.
Publicado: (2013)

Maximizing the benefits of antiretroviral therapy for key affected populations
por: Grubb, Ian R, et al.
Publicado: (2014)

Antiretroviral postnatal prophylaxis to prevent HIV vertical transmission: present and future strategies
por: Penazzato, Martina, et al.
Publicado: (2023)

Highly active antiretroviral therapy and dyslipidemia in people living with HIV/AIDS in Fako Division, South West Region of Cameroon
por: Nsagha, Dickson Shey, et al.
Publicado: (2015)

The Role of Dyslipidemia Control in the Progression of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus
por: Chatziralli, Irini P.
Publicado: (2017)

Beta-2 Agonism: A Potential Therapeutic Target for Dyslipidemia
por: Davidson, Michael H.
Publicado: (2015)

Immediate Antiretroviral Therapy: The Need for a Health Equity Approach
por: Mgbako, Ofole, et al.
Publicado: (2020)

The HIV drug optimization agenda: promoting standards for earlier investigation and approvals of antiretroviral drugs for use in adolescents living with HIV
por: Rojo, Pablo, et al.
Publicado: (2020)

Early antiretroviral treatment of infants to attain HIV remission: Not just a matter of timing
por: Faye, Albert
Publicado: (2020)

Outcomes of modern antiretroviral therapy in obese individuals living with HIV
por: Zino, L, et al.
Publicado: (2022)

Antiretroviral treatment-induced dyslipidemia in HIV-infected patients is influenced by the APOC3-related rs10892151 polymorphism
por: Aragonès, Gerard, et al.
Publicado: (2011)

Vitamin D deficiency in hyperthyroidism
por: Dhanwal, Dinesh K.
Publicado: (2012)

Central Nervous System Strongyloidiasis and Cryptococcosis in an HIV-Infected Patient Starting Antiretroviral Therapy
por: Rodríguez, Mónica, et al.
Publicado: (2012)

Obesity and Dyslipidemia in South Asians
por: Misra, Anoop, et al.
Publicado: (2013)

Dyslipidemia and Obesity in Ischemic Stroke
por: Gajurel, Bikram P, et al.
Publicado: (2023)

Centrality of telomerase in cellular life
por: Mishra, Deepak Kumar, et al.
Publicado: (2019)

Association of Perinatal Factors With Severe Obesity and Dyslipidemia in Adulthood
por: Tadese, Kristene, et al.
Publicado: (2022)

Compartmentalized HIV rebound in the central nervous system after interruption of antiretroviral therapy
por: Gianella, Sara, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_avp9v94542gs8fr5nj2fh4k2ht